MARATTO

article · SVU-International Journal of Medical Sciences

Pattern of Hospital-Acquired Pneumonia in Qena University Hospitals

Abstract

Background: Hospital-acquired pneumonia (HAP) is a significant concern in ICU patients, with a higher morbidity, decease rate, and increased resource use.Objectives: The study aimed to identify the causative bacteria, antibiotic sensitivity, and resistance among the cases with hospital-acquired pneumonia in Qena university hospitals.Patients and methods: A cross-sectional study including 70 HAP patients at QUH during the period of one year. The demographics, full clinical evaluations, laboratory investigations, and radiography were collected.Results: This study involved 70 cases with positive cultures, Elderly patients with chronic chest disease, and COPD exacerbation was the main reason for admission. Bilateral lung consolidation was the commonest radiological finding. Gram-negative bacilli were the most prevalent strain among the study cohort. Gentamycin, chloramphenicol, and amikacin were the most effective antibiotics against blood culture organisms, while imipenem and meropenem were the most effective antibiotics against the sputum culture organisms. Resistance was observed with various antibiotics. The decease rate was 21.43%.Conclusion: Hospital-acquired pneumonia (HAP) mainly affects older individuals, Gram-negative bacilli were commonly found in cultures, emphasizing their importance in diagnosis. Antibiotic sensitivity and resistance patterns varied, highlighting the necessity for tailored antibiotic selection based on microbiology results.

Research topics

  • Pneumonia and Respiratory Infections
  • Emergency and Acute Care Studies

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21608/svuijm.2023.230200.1656

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.